-+ 0.00%
-+ 0.00%
-+ 0.00%

Venrock Healthcare Capital Partners III and Affiliates Report Acquisition of $37.65 Million in Lycia Therapeutics Common Shares

PUBT·10/27/2026 22:38:57
Listen to the news
Venrock Healthcare Capital Partners III and Affiliates Report Acquisition of $37.65 Million in Lycia Therapeutics Common Shares
  • Venrock-affiliated funds reported beneficial ownership of 6,825,233 Lycia Therapeutics common shares.
  • Purchases included 1,944,444 common shares at $18 per share.
  • Conversion of Series C Preferred Stock and Series D Preferred Stock added 4,779,793 common shares.
  • Bong Y. Koh and Nimish P. Shah were listed as reporting 10% owners.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lycia Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-001503), on October 27, 2026, and is solely responsible for the information contained therein.